Gustavo Nader Marta, Radiation Oncologist at Sírio-Libanês Hospital, shared on LinkedIn:
“Five-fraction radiotherapy. 99.7% locoregional control at 5 years. Zero severe toxicity.
In 460 Brazilian patients treated across public and private institutions, ultra-hypofractionation confirmed what the trials already suggested — now with real-world data from Brazil. Fewer hospital visits, broader access, same outcome.
Published in Clinical Breast Cancer, with LACOG support.”
Title: Ultra-Hypofractionation in Breast Cancer: A Multicenter Retrospective Cohort Study in Brazil
Authors: Gustavo Nader Marta, Liêvin Matos Rebouças, Priscilla Furtado Souza Pasquinelli, Harley Francisco de Oliveira, Maria Carolina Lopes Perdigão, Guilherme Rocha Melo Gondim, Roberta Kramer Guedes Calixto da Silva, Rodrigo de Morais Hanriot, Mariana Paranhos Alvarenga, Gustavo Pereira Maciel, Leticia Hernandes de Brito, Rafael Lopes de Oliveira, Naira dos Santos Gutierrez, Emily Tonin da Costa, Vitória Silva Garcia, and Samir Abdallah Hanna.
Read the article here.
You may also be interested in:
- Paolo Tarantino: Celebrating 20 Years of the Translational Breast Cancer Research Consortium
- Damir Vučinić Discusses SBRT in Metastatic Breast Cancer at HDIO 2026